Article Text

other Versions

PDF
Quantitative study
Postmenopausal women with medically treated diabetes have increased risk of lung cancer
  1. Michael Leitzmann
  1. Department of Epidemiology and Preventive Medicine, Regensburg University, Regensburg, Germany
  1. Correspondence to: Dr Michael Leitzmann
    Department of Epidemiology and Preventive Medicine, Regensburg University, Franz-Josef-Strauss-Allee 11, Regensburg 93053, Germany; michael.leitzmann{at}klinik.uni-regensburg.de

Statistics from Altmetric.com

Commentary on: Luo J, Chlebowski R, Wactawski-Wende J, et al. Diabetes and lung cancer among postmenopausal women. Diabetes Care 2012;35:1485–91.

Implications for practice and research

  • Lung cancer may potentially be added to the list of cancers directly related to diabetes or insulin treatment.

  • Current evidence is insufficient to consider lung cancer risk as the basis for selecting appropriate diabetes therapy.

  • Diabetes patients who require insulin therapy for metabolic control should continue to be treated with insulin.

Context

Considerable epidemiological evidence suggests that type 2 diabetes is associated with increased risk of developing various types of malignancies, most notably cancers of the liver, pancreas, endometrium, colorectum, breast and bladder. In contrast, type 2 diabetes has previously not been widely thought to be linked with lung cancer.1 The relation of diabetes to lung cancer …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.